There is a significant level of heregulin, the primary ligand of HER2/HER3 heterodimers, in the human brain, and a growing body of evidence suggests that it promotes the trans-endothelial migration of HER2/HER3-positive BC cells across the brain microvascular endothelia. Here, ERBB2 is linked to breast cancer.